Future research on FANCI will likely focus on elucidating its detailed mechanisms in DNA repair and its interactions with other proteins involved in cancer pathways. There is also significant interest in developing novel therapeutic agents that can target FANCI deficiencies more effectively. Additionally, ongoing studies aim to better understand how FANCI mutations contribute to cancer heterogeneity and treatment resistance.
